GE HealthCare Technologies Inc. (GEHC) Income Statement
GEHC 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsGEHC revenue and net income
Where GEHC's revenue goes
2025Each bar shows an amount and its share of revenue. GEHC kept 10.1% of revenue as net income.
GEHC profit margins
GEHC growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | +4.8% | +4.0% | +3.7% | — |
| Gross profit | +0.5% | +4.7% | +4.0% | — |
| Operating income | +5.2% | +3.1% | +0.3% | — |
| Net income | +4.6% | +2.8% | −31.5% | — |
| EPS (diluted) | −0.7% | +2.8% | — | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
GEHC quarterly EPS vs estimates
GE HealthCare beat the analyst EPS estimate in 7 of the last 8 quarters. Next report: October 28, 2026 (estimate $1.21).
GEHC income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Revenue | $20.62B | $19.67B | $19.55B | $18.34B | $17.59B | $17.16B | $16.63B |
| Cost of revenue | $12.38B | $11.47B | $11.63B | $11.16B | $10.41B | $10.40B | $10.09B |
| Gross profit | $8.25B | $8.21B | $7.92B | $7.18B | $7.17B | $6.77B | $6.55B |
| Research & development | $1.26B | $1.31B | $1.21B | $1.03B | $816.0M | $810.0M | $833.0M |
| Sales, general & admin | $4.15B | $4.27B | $4.28B | $3.63B | $3.56B | $3.24B | $3.59B |
| Total operating expenses | $5.49B | $5.58B | $5.49B | $4.66B | $4.38B | $4.05B | $4.42B |
| Operating income | $2.76B | $2.62B | $2.44B | $2.52B | $2.79B | $2.72B | $2.12B |
| Interest income | $41.0M | — | $26.0M | — | $34.0M | $49.0M | $36.0M |
| Interest expense | $450.0M | $505.0M | $542.0M | $86.0M | $40.0M | $66.0M | $88.0M |
| Income before taxes | $2.77B | $2.58B | $2.36B | $2.51B | $2.88B | $2.71B | $2.09B |
| Income taxes | $614.0M | $531.0M | −$743.0M | $563.0M | $600.0M | $652.0M | $410.0M |
| Net income | $2.08B | $1.99B | $3.10B | $1.92B | $2.25B | $13.85B | $1.52B |
| EBITDA | $3.79B | $3.67B | $2.44B | $3.17B | $3.54B | $3.41B | $2.84B |
| EPS (diluted) | $4.58 | $4.61 | $3.94 | $4.22 | $4.94 | — | — |
| Gross margin | 40.0% | 41.7% | 40.5% | 39.1% | 40.8% | 39.4% | 39.4% |
| Operating margin | 13.4% | 13.3% | 12.5% | 13.8% | 15.9% | 15.8% | 12.8% |
| Net margin | 10.1% | 10.1% | 15.9% | 10.4% | 12.8% | 80.7% | 9.2% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.29B | $5.13B | $4.67B | $5.14B | $5.01B | $4.78B | $5.32B | $4.86B | $4.84B | $4.65B | $5.21B | $4.82B |
| Cost of revenue | $3.12B | $3.15B | $2.13B | $3.15B | $3.02B | $2.77B | $3.04B | $2.84B | $2.84B | $2.75B | $3.05B | $2.89B |
| Gross profit | $2.18B | $1.98B | $2.54B | $1.99B | $1.99B | $2.01B | $2.27B | $2.03B | $2.00B | $1.90B | $2.16B | $1.94B |
| Research & development | $323.0M | $345.0M | $362.0M | $292.0M | $302.0M | $344.0M | $344.0M | $316.0M | $327.0M | $324.0M | $315.0M | $322.0M |
| Sales, general & admin | $1.12B | $1.12B | $1.11B | $1.04B | $1.03B | $1.04B | $1.13B | $1.03B | $1.07B | $1.04B | $1.15B | $996.0M |
| Total operating expenses | $1.44B | $1.46B | $1.88B | $1.34B | $1.33B | $1.38B | $1.47B | $1.35B | $1.39B | $1.36B | $1.47B | $1.32B |
| Operating income | $739.0M | $515.0M | $664.0M | $653.0M | $654.0M | $629.0M | $801.0M | $676.0M | $608.0M | $540.0M | $689.0M | $617.0M |
| Interest income | $7.0M | — | $24.0M | $12.0M | $6.0M | — | — | $5.0M | $0 | — | $7.0M | $6.0M |
| Interest expense | $114.0M | $96.0M | $103.0M | $123.0M | $113.0M | $111.0M | $111.0M | $130.0M | $131.0M | $138.0M | $131.0M | $138.0M |
| Income before taxes | $693.0M | $505.0M | $202.0M | $643.0M | $613.0M | $692.0M | $834.0M | $658.0M | $578.0M | $512.0M | $609.0M | $636.0M |
| Income taxes | $119.0M | $94.0M | $54.0M | $179.0M | $113.0M | $104.0M | $96.0M | $168.0M | $143.0M | $124.0M | $193.0M | $250.0M |
| Net income | $573.0M | $389.0M | $184.0M | $446.0M | $486.0M | $564.0M | $720.0M | $471.0M | $428.0M | $374.0M | $403.0M | $375.0M |
| EBITDA | $953.0M | $755.0M | $463.0M | $902.0M | $874.0M | $939.0M | $1.08B | $931.0M | $858.0M | $798.0M | $899.0M | $927.0M |
| EPS (diluted) | $1.13 | $0.99 | $1.44 | $1.07 | $1.06 | $1.01 | $1.57 | $1.14 | $1.00 | $0.90 | $1.18 | $0.99 |
| Gross margin | 41.2% | 38.5% | 54.3% | 38.7% | 39.7% | 42.1% | 42.8% | 41.7% | 41.4% | 40.9% | 41.4% | 40.1% |
| Operating margin | 14.0% | 10.0% | 14.2% | 12.7% | 13.1% | 13.2% | 15.1% | 13.9% | 12.6% | 11.6% | 13.2% | 12.8% |
| Net margin | 10.8% | 7.6% | 3.9% | 8.7% | 9.7% | 11.8% | 13.5% | 9.7% | 8.8% | 8.0% | 7.7% | 7.8% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in GEHC's financial statements (latest annual report filed February 4, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
GEHC financial results
In fiscal year 2025 (ended December 31, 2025), GE HealthCare reported revenue of $20.6 billion, up 4.8% from the year before. It had net income of $2.1 billion (up 4.6%), a net profit margin of 10.1%. Diluted earnings per share came to $4.58. Over five years revenue grew at an average rate of 3.7% a year.
See the GEHC stock overview for the latest quote and news, or the GEHC chart for price history and technical indicators.
GEHC income statement FAQ
What is GE HealthCare's annual revenue?
GE HealthCare reported total revenue of $20.6 billion for fiscal year 2025, which ended on December 31, 2025. That was up 4.8% from $19.7 billion the previous year.
Is GE HealthCare profitable?
Yes. GE HealthCare reported net income of $2.1 billion in fiscal 2025, a net profit margin of 10.1%; its operating margin was 13.4%.
What is GE HealthCare's gross margin?
GE HealthCare's gross margin was 40.0% in fiscal 2025: for every $100 of revenue, GE HealthCare kept $40 after the direct cost of its products and services.
How much does GE HealthCare spend on research and development?
GE HealthCare spent $1.3 billion on research and development in fiscal 2025, 6.1% of revenue.
How fast is GE HealthCare growing?
Revenue grew 3.7% a year on average over the last five fiscal years, from $17.2 billion to $20.6 billion.
What are GE HealthCare's earnings per share?
GE HealthCare earned $4.58 per diluted share in fiscal 2025, compared with $4.61 a year earlier.
When will GE HealthCare report its next earnings?
GE HealthCare is expected to report results for the quarter ending September 30, 2026 on October 28, 2026 before the market opens.
When does GE HealthCare's fiscal year end?
GE HealthCare's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on February 4, 2026.